Ken Griffin Citadel Advisors
Ken Griffin founded Citadel, one of the world’s largest and most successful hedge funds. Starting his trading career from his Harvard dorm room at a young age, Griffin quickly developed a keen sense for markets and built Citadel into a global powerhouse with billions in assets under management. Known for his quantitative and technology-driven strategies, Griffin has also made headlines for significant philanthropic contributions, supporting causes in education, the arts, and public institutions. Over the years, he has earned recognition as one of the preeminent figures in modern finance.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Meta Platforms (Facebook)
META
|
+$772M |
| 2 |
Eli Lilly
LLY
|
+$337M |
| 3 |
lululemon athletica
LULU
|
+$301M |
| 4 |
iShares iBoxx $ High Yield Corporate Bond ETF
HYG
|
+$297M |
| 5 |
ResMed
RMD
|
+$273M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$576M |
| 2 |
AT&T
T
|
+$476M |
| 3 |
PNC Financial Services
PNC
|
+$393M |
| 4 |
Fortive
FTV
|
+$389M |
| 5 |
Accenture
ACN
|
+$374M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 2.83% |
| 2 | Technology | 2.79% |
| 3 | Financials | 2.29% |
| 4 | Consumer Discretionary | 1.93% |
| 5 | Industrials | 1.63% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3976
CALL
SBA Communications
SBAC
$19.6B
| $4.35M | ﹤0.01% |
13,600
-5,300
| -28% | -$1.79M |
|
3977
CALL
Vanguard FTSE Europe ETF
VGK
$31.1B
| $4.35M | ﹤0.01% |
82,400
-111,200
| -57% | -$6.45M |
|
3978
CALL
New Oriental
EDU
$8.36B
| $4.35M | ﹤0.01% |
213,720
+181,370
| +561% | +$2.48M |
|
|
NEWR
3979
DELISTED
New Relic, Inc.
NEWR
| $4.35M | ﹤0.01% |
86,902
-973,157
| -92% | -$54M |
|
|
MNDT
3980
PUT
DELISTED
Mandiant, Inc. Common Stock
MNDT
| $4.35M | ﹤0.01% |
199,200
-983,400
| -83% | -$21.6M |
|
|
XIFR
3981
CALL
XPLR Infrastructure LP
XIFR
$1.11B
| $4.35M | ﹤0.01% |
58,600
-2,400
| -4% | -$172K |
|
3982
iShares MSCI Intl Momentum Factor ETF
IMTM
$4.33B
| $4.34M | ﹤0.01% |
145,186
+89,313
| +160% | +$2.89M |
|
|
CAJ
3983
DELISTED
Canon, Inc.
CAJ
| $4.34M | ﹤0.01% |
191,208
+39,306
| +26% | +$949K |
|
3984
Ameresco
AMRC
$1.48B
| $4.34M | ﹤0.01% |
95,165
-111,111
| -54% | -$6.18M |
|
3985
PUT
Vanguard High Dividend Yield ETF
VYM
$84B
| $4.33M | ﹤0.01% |
42,600
-6,200
| -13% | -$672K |
|
3986
Dorian LPG
LPG
$2.03B
| $4.33M | ﹤0.01% |
284,954
+244,319
| +601% | +$3.87M |
|
3987
PUT
Tapestry
TPR
$25.7B
| $4.33M | ﹤0.01% |
141,900
-91,900
| -39% | -$3.01M |
|
3988
CALL
Cincinnati Financial
CINF
$26.6B
| $4.32M | ﹤0.01% |
36,300
+21,900
| +152% | +$2.78M |
|
3989
PUT
Coty
COTY
$2.51B
| $4.32M | ﹤0.01% |
539,000
-75,100
| -12% | -$564K |
|
3990
CALL
Xcel Energy
XEL
$49.5B
| $4.32M | ﹤0.01% |
61,000
-19,300
| -24% | -$1.4M |
|
3991
Kimbell Royalty Partners
KRP
$1.52B
| $4.3M | ﹤0.01% |
274,558
+231,096
| +532% | +$4.02M |
|
|
HCII
3992
DELISTED
Hudson Executive Investment Corp. II Class A Common Stock
HCII
| $4.3M | ﹤0.01% |
437,500
-350,000
| -44% | -$3.43M |
|
3993
PUT
AdvisorShares Pure US Cannabis ETF
MSOS
$930M
| $4.3M | ﹤0.01% |
415,500
-146,800
| -26% | -$2.18M |
|
3994
Energy Fuels
UUUU
$3.77B
| $4.29M | ﹤0.01% |
874,868
+545,842
| +166% | +$3.86M |
|
3995
State Street SPDR S&P Emerging Asia Pacific ETF
GMF
$439M
| $4.29M | ﹤0.01% |
41,719
-625
| -1% | -$65K |
|
3996
CALL
Protagonist Therapeutics
PTGX
$10B
| $4.29M | ﹤0.01% |
542,300
+417,600
| +335% | +$5.05M |
|
3997
CALL
Arrowhead Research
ARWR
$12.2B
| $4.29M | ﹤0.01% |
121,800
-50,700
| -29% | -$1.91M |
|
3998
Helmerich & Payne
HP
$4.42B
| $4.29M | ﹤0.01% |
99,562
+55,533
| +126% | +$2.58M |
|
3999
Vanguard International High Dividend Yield ETF
VYMI
$21.3B
| $4.29M | ﹤0.01% |
+72,879
| New | +$4.66M |
|
|
ATCO
4000
DELISTED
Atlas Corp.
ATCO
| $4.29M | ﹤0.01% |
400,140
+7,427
| +2% | +$93.3K |
|
Similar funds
Ken Griffin's Q2 2022 Portfolio in Review
As of Q2 2022, Ken Griffin held 14,957 positions worth $390B, down 20% from $484B the previous quarter. Its ten largest holdings account for 28% of the portfolio.
Ken Griffin's Q2 2022 filing shows 1,520 new, 5,503 increased, 5,522 reduced and 2,191 closed positions. Its largest new stake was ResMed: 1,280,595 shares worth $268M. The largest sale was State Street SPDR S&P 500 ETF Trust, an estimated $576M.
By sector, the portfolio is most concentrated in Healthcare at 2.8% of assets, up from 2.4% a quarter earlier, followed by Technology and Financials.
- Ken Griffin's largest Q2 2022 buy was ResMed: 1,280,595 shares worth $268M.
- Ken Griffin added most to Meta Platforms (Facebook) in Q2 2022, an estimated $772M increase.
- Ken Griffin's biggest Q2 2022 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $576M.
- Ken Griffin fully exited Vanguard Morningstar Small-Cap ETF in Q2 2022, selling an estimated $184M.
- Ken Griffin's ten largest holdings make up 28% of its $390B portfolio in Q2 2022.
- Ken Griffin opened 1,520 new positions and closed 2,191 in Q2 2022.
- Ken Griffin's portfolio value fell 20% quarter-over-quarter to $390B.
Based on Citadel Advisors's 13F filing for Q2 2022, filed 15 Aug 2022.